Cardiac pacemaker: Interventions
Interventions
Changes that would cut emissions or material use, by lever and life stage, with effect per unit, readiness, adoption, evidence and who acts
| Lever | Life stage | Change | Effect per unit | Readiness | Adoption | Who acts | Source |
|---|---|---|---|---|---|---|---|
| Circularity | End of life | Reuse explanted pacemakers that still have battery life | One reconditioned device replaces a new one; in a randomised trial of 306 patients, 12-month procedure-related infection was 1.6% for reconditioned and 3.1% for new devices [14] | Piloted (randomised controlled trial in seven countries, ESC Congress 2025) | Reuse is prohibited in the United States; re-sterilised devices may be exported for reuse [13] | Regulators, hospitals, charities | [14][13] |
| Design | Components design | Leadless design, with generator and electrode in one capsule | The Micra weighs 1.75 g and fills 0.8 cc [2]; four BIOTRONIK Evia models weigh 24 to 26 g [1] (maker table values; different makers, no like-for-like comparison) | Deployed (FDA approval April 2016 [6]) | Not given in any source opened | Device makers | [2][1][6] |
| Efficiency | Use | Longer battery life, so fewer replacement operations | Replacements were 264,824 of 1,002,664 implants in 2009 (26.4%, calculated) [4]; lithium iodine cells last about 10 years [3], the Micra AV2 is listed at 8 to 13 years [2] | Deployed | Not given in any source opened | Device makers | [4][3][2] |
| Use less | Use | Remote monitoring of pacemakers in place of clinic visits | A 2023 review says remote monitoring of pacemaker devices can reduce emissions; its Table 2 gives one study's 15 kg CO2e saved per remote monitoring cycle, a per-cycle figure from one Spanish programme, not a per-device figure [20] | Deployed | Not given in any source opened | Hospitals, device makers | [20] |
as of 2026-11-13
Sources
- BIOTRONIK EVIA User And Technical Manual BIOTRONIK (copy hosted on manualmachine.com), 2009, Doc. Id. 365353-A, cover dated 23.04.2009; mechanical characteristics, battery data and service time tables; explantation and disposal section
- Micra AV and Micra VR leadless pacemakers for bradyarrhythmia management Medtronic (India site), 2024, specification table; page footer says last updated March 2024
- A Look Back: 85 Years of Cardiac Pacing EP Lab Digest (HMP Global Learning Network), B. J. Wilhelm and B. Osswald, 2014, September 2014
- The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009 - a World Society of Arrhythmia's project Pacing and Clinical Electrophysiology (Mond and Proclemer), on PubMed, 2011, abstract
- Premarket Approval (PMA): Medtronic Micra Transcatheter Pacemaker System, P150033 US Food and Drug Administration, Decision Date 04/06/2016; applicant Medtronic, Inc.
- Reconditioned pacemakers worked as well as new ones American Heart Association newsroom, 2024, dated 17 November 2024; the study abstract was not peer reviewed, as the page says
- Reconditioned pacemakers provide new hope for patients in low- and middle-income countries European Society of Cardiology (press release), 2025, dated 1 September 2025, ESC Congress
- Environmental impact of cardiovascular healthcare Open Heart (BMJ), Barratt and others, Open Heart 2023;10:e002279, 2023, abstract; Table 2 (Study findings), Perez Diaz et al. row